Neogene Therapeutics is a pre-clinical stage biotechnology company pioneering the development of next-generation, fully personalized engineered T cells therapies for a broad spectrum of cancers. The company’s engineered T cells target mutation-derived tumor neo-antigens thereby rendering tumor cells vulnerable to detection and destruction. Neogene’s proprietary technology platform enables the identification of TCR genes with specificity for neo-antigens from a tumor biopsy. Neogene’s novel platform delivers a tailored set of TCR genes for each individual patient thereby enabling fully personalized engineered T cell therapy for cancer.
For our Research and Department team in Amsterdam, we are seeking a highly motivated individual to join our TCR discovery team as a (Senior) Scientist. The individual will use existing and develop novel single-cell technologies to drive innovation of our TCR discovery platform.
Responsibilities include, but are not limited to:
Requirements:
We offer the opportunity to join a highly dynamic growth-stage biotech company. You can expect a collaborative environment created by a team with deep scientific expertise and an industrial track-record in T cell therapies. We value pro-active team-players who pursue their goals with dedication, endurance and a daring mindset. If you share our commitment to make a difference to patients in need, we can provide a unique opportunity to be a major contributor to the success of a well-positioned, well-financed growth-stage biotechnology company.
If you are interested please submit your electronic application including cover letter and CV to careers@neogene.com
No recruiters. No phone calls.
Neogene Therapeutics
689 Fifth Avenue
12th Floor
New York, NY 10022
Neogene Therapeutics
Science Park 106
1098 XG Amsterdam
The Netherlands
©2020 Neogene Therapeutics. Visit our cookie policy.
Neogene Therapeutics
689 Fifth Avenue, 12th Floor | New York, NY 10022
Neogene Therapeutics
Science Park 106
1098 XG Amsterdam | The Netherlands
©2020 Neogene Therapeutics. Visit our cookie policy.